Rifampicin susceptibility discordance between Xpert MTB/RIF G4 and Xpert Ultra before MDRT-TB treatment initiation: A case report from Uganda

Rifampicin susceptibility discordance between Xpert MTB/RIF G4 and Xpert Ultra before MDRT-TB treatment initiation: A case report from Uganda

Tuberculosis (TB) resistance to rifampicin, the most powerful drug leads to increase in mortality. Globally, half a million new patients develop such resistant TB each year, coupled with both inappropriate diagnosis and treatment initiation.We report a case of rifampicin resistant Mycobacterium tube...

Full description

Bibliographic Details
Main Authors: Willy Ssengooba, Kevin Komakech, Sharon Namiiro, Henry Byabajungu, Joanitah Nalunjogi, Winceslaus Katagira, Ivan Kimuli, Moses L Joloba, Susan Adakun, Lydia Nakiyingi, Gabriela Torrea, Bruce J Kirenga
Format: Article
Language:English
Published: Elsevier 2021-12-01
Series:Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
Subjects:
XpertMTB/RIF
G4
ULTRA
Rifampicin
Discordance
Online Access:http://www.sciencedirect.com/science/article/pii/S2405579421000759

Internet

http://www.sciencedirect.com/science/article/pii/S2405579421000759

Similar Items